Sentence examples for drug application process from inspiring English sources

Related sites Announcement about new initiative Information on FDA's drug application process.

The agency is confronting pressure from pharmaceutical and biotechnology companies to streamline and speed up the drug application process, budgetary concerns stemming from relatively stagnant public funding over the last several years, and disputes over subjects ranging from biological warfare to the regulation of genetically modified foods.

There is little on quality assurance and regulation, such as the investigational new drug application process and current good manufacturing practice, although good clinical practice is mentioned.

42 43 44 45 In 1995, US, European, and Japanese regulators along with the respective industry trade organisations established a standardised way to organise a CSR to help simplify the new drug application process across global regulatory regimes.

http://www.mged.org/ Guidance for Industry: Pharmacogenomic Data Submission This guidance, issued by the FDA in draft form in November 2003, contains nonbinding recommendations on the submission of pharmacogenomics data during the drug application process.

Heterogeneity of response makes the traditional drug development and application process slow, costly and inefficient (Adams and Brantner, 2006; Yap et al, 2010).

However, to account for the temporal extension of the drug activity, we model drug application as a temporal process extending over at least 24 h instead of modelling single-application events with sophisticated pharmacokinetics.

In this respect, Tan et al. suggest that institutions should clearly state a hierarchy of priorities before any discussion on including a drug is made [ 31], and Schiff et al., propose a Formulary Drug Application Tool, which they suggest might help DTC members to evaluate claims about drugs made during the application process, giving a framework to improve the level of the discussion [ 32].

However, this document acknowledges that a basis exists for conducting human studies on food (including dietary supplements) that do not require the same IND application process as drug studies; such studies will need to avoid drug-type endpoints.

ADM is a very sticky molecule [32], and this might add risk in the drug production and application processes.

But according to a report by the Globe and Mail, the company bringing the drug here, Celopharma, has opted out of an application process that is required for the drug to be covered by the provinces.